215 related articles for article (PubMed ID: 8808781)
41. Vancomycin release from poly(D,L-lactide) and poly(lactide-co-glycolide) disks.
Ozalp Y; Ozdemir N; Hasirci V
J Microencapsul; 2002; 19(1):83-94. PubMed ID: 11811762
[TBL] [Abstract][Full Text] [Related]
42. Controlled release of vancomycin from biodegradable microcapsules.
Ozalp Y; Ozdemir N; Kocagöz S; Hasirci V
J Microencapsul; 2001; 18(1):89-110. PubMed ID: 11201344
[TBL] [Abstract][Full Text] [Related]
43. Preparation of biodegradable microcapsules containing zidovudine (AZT) using solvent evaporation technique.
Mandal TK; Lopez-Anaya A; Onyebueke E; Shekleton M
J Microencapsul; 1996; 13(3):257-67. PubMed ID: 8860682
[TBL] [Abstract][Full Text] [Related]
44. Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres.
Hsu YY; Hao T; Hedley ML
J Drug Target; 1999 Dec; 7(4):313-23. PubMed ID: 10682910
[TBL] [Abstract][Full Text] [Related]
45. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
[TBL] [Abstract][Full Text] [Related]
46. Reduction in burst release after coating poly(D,L-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer.
Ahmed AR; Elkharraz K; Irfan M; Bodmeier R
Pharm Dev Technol; 2012; 17(1):66-72. PubMed ID: 20854130
[TBL] [Abstract][Full Text] [Related]
47. Poly(lactic acid)/N-maleoylchitosan core-shell capsules: preparation and drug release properties.
Zhu A; Li F; Ji L
Colloids Surf B Biointerfaces; 2012 Mar; 91():162-7. PubMed ID: 22100385
[TBL] [Abstract][Full Text] [Related]
48. Dissolution, stability, and morphological properties of conventional and multiphase poly(DL-lactic-co-glycolic acid) microspheres containing water-soluble compounds.
Iwata M; McGinity JW
Pharm Res; 1993 Aug; 10(8):1219-27. PubMed ID: 8415411
[TBL] [Abstract][Full Text] [Related]
49. Double-walled microspheres loaded with meglumine antimoniate: preparation, characterization and in vitro release study.
Navaei A; Rasoolian M; Momeni A; Emami S; Rafienia M
Drug Dev Ind Pharm; 2014 Jun; 40(6):701-10. PubMed ID: 23594302
[TBL] [Abstract][Full Text] [Related]
50. Microencapsulation using poly(DL-lactic acid). I: Effect of preparative variables on the microcapsule characteristics and release kinetics.
Jalil R; Nixon JR
J Microencapsul; 1990; 7(2):229-44. PubMed ID: 2329448
[TBL] [Abstract][Full Text] [Related]
51. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
Duvvuri S; Janoria KG; Mitra AK
J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
[TBL] [Abstract][Full Text] [Related]
52. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
Chaisri W; Ghassemi AH; Hennink WE; Okonogi S
Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499
[TBL] [Abstract][Full Text] [Related]
53. Microencapsulation using poly(DL-lactic acid). II: Effect of polymer molecular weight on the microcapsule properties.
Jalil R; Nixon JR
J Microencapsul; 1990; 7(2):245-54. PubMed ID: 2329449
[TBL] [Abstract][Full Text] [Related]
54. Altering the drug release profiles of double-layered ternary-phase microparticles.
Lee WL; Loei C; Widjaja E; Loo SC
J Control Release; 2011 May; 151(3):229-38. PubMed ID: 21352877
[TBL] [Abstract][Full Text] [Related]
55. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
Duvvuri S; Janoria KG; Pal D; Mitra AK
J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
[TBL] [Abstract][Full Text] [Related]
56. β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release.
Song X; Song SK; Zhao P; Wei LM; Jiao HS
Pharm Dev Technol; 2013; 18(5):1220-9. PubMed ID: 22295954
[TBL] [Abstract][Full Text] [Related]
57. Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method.
Uchida T; Yagi A; Oda Y; Goto S
J Microencapsul; 1996; 13(5):509-18. PubMed ID: 8864988
[TBL] [Abstract][Full Text] [Related]
58. Optimisation of aciclovir poly(D,L-lactide-co-glycolide) microspheres for intravitreal administration using a factorial design study.
Martínez-Sancho C; Herrero-Vanrell R; Negro S
Int J Pharm; 2004 Apr; 273(1-2):45-56. PubMed ID: 15010129
[TBL] [Abstract][Full Text] [Related]
59. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
60. A calorimetric study on diflunisal release from poly(lactide-co-glycolide) microspheres by monitoring the drug effect on dipalmitoylphosphatidylcholine liposomes: temperature and drug loading influence.
Castelli F; Giunchedi P; La Camera O; Conte U
Drug Deliv; 2000; 7(1):45-53. PubMed ID: 10895419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
